Daclahep (30 mg Tablets , 60 mg)

Hetero Healthcare Ltd. (INDIA)

DACLAHEP contains Drug / Molecule called “DACLATASVIR”. It is used for the treatment of patients with chronic Hepatitis C virus (HCV). It inhibits the Hepatitis C Virus (HCV) nonstructural protein; by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

Indication

Daclahep is used for treatment of patients with chronic Hepatitis C.

Note

Precaution

  • Cases of severe bradycardia and heart block have been observed when used in combination with sofosbuvir with or without other drugs that lower heart rate.
  • Daclahep should not be used during pregnancy or in women of childbearing potential not using contraception.